Legacy & Innovation
Nearly 50 Years
of Prostaglandin
Expertise
The merger of two world-class entities.
Our journey is defined by a relentless pursuit of pharmaceutical precision. By uniting transatlantic research excellence with European manufacturing mastery, we have created a singular force in the prostaglandin industry.
The Evolution of Excellence
1978
Initiation
Prostaglandin development initiated in Spolana in collaboration with the Chemical Institute of Technology in Prague.
1979
Development
Successful development of (±)-CLOPROSTENOL manufacturing.
“Today, Cayman Pharma represents the accumulation of almost 50 years of synthesis experience, bridging the gap between cutting-edge research and global GMP manufacturing.”
A Cayman Pharma Company